DrugPatentWatch Database Preview
Drugs in Development Information for Ganetespib
What is the drug development status for Ganetespib?
Ganetespib is an investigational drug.
There have been 31 clinical trials for Ganetespib.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Lung Neoplasms, Breast Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are Synta Pharmaceuticals Corp., Dana-Farber Cancer Institute, and Emory University.
There are twenty US patents protecting this investigational drug and three hundred and thirty-five international patents.
Summary for Ganetespib
| US Patents | 20 |
| International Patents | 335 |
| US Patent Applications | 77 |
| WIPO Patent Applications | 50 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2013-04-01) |
| Vendors | 56 |
Recent Clinical Trials for Ganetespib
| Title | Sponsor | Phase |
|---|---|---|
| European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer | European Commission | Phase 2 |
| European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer | Universitaire Ziekenhuizen Leuven | Phase 2 |
| A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer | University of Chicago | N/A |
Clinical Trial Summary for Ganetespib
Top disease conditions for Ganetespib
Top clinical trial sponsors for Ganetespib
US Patents for Ganetespib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ganetespib | Start Trial | Resorcinol derivative as HSP90 inhibitor | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (Lianyungang, CN) | Start Trial |
| Ganetespib | Start Trial | Pyrimidine-diamine dual HSP90/TRAP1 inhibitors | Calasia Pharmaceuticals, Inc. (San Diego, CA) | Start Trial |
| Ganetespib | Start Trial | Triazole compounds that modulate Hsp90 activity | Synta Pharmaceuticals Corp. (Lexington, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ganetespib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ganetespib | Australia | 2016208863 | 2035-01-22 | Start Trial |
| Ganetespib | Canada | 2974756 | 2035-01-22 | Start Trial |
| Ganetespib | China | 107108591 | 2035-01-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
